Complications of coinfection with Babesia and Lyme disease after splenectomy.
Abrams
Ya'aqov
Y
Department of Family and Community Medicine, University of Pittsburgh, PA 15217, USA. abramsym@upmc.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D053626:Atovaquone / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D001404:Babesiosis / Q000150:complications* / Q000188:drug therapy; D002738:Chloroquine / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008193:Lyme Disease / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013156:Splenectomy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D017963:Azithromycin; D002738:Chloroquine; D004318:Doxycycline; D053626:Atovaquone